Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.
about
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathwayMetabolic profiling of laser microdissected vascular bundles of Arabidopsis thalianaThe epidermal growth factor receptor variant III (EGFRvIII): where wild things are alteredThe receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingDevelopment of an EGFRvIII specific recombinant antibodyEpidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation.EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Antibody-based immunotherapy for malignant glioma.An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiformeA monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.Immunotherapy for malignant gliomaIn Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment.Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients.Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cellsEpidermal growth factor receptor inhibition and non-small cell lung cancer.Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancerTumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.EGF receptor variant III as a target antigen for tumor immunotherapy.EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.Toward effective immunotherapy for the treatment of malignant brain tumorsNuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Targeting the epidermal growth factor receptor in solid tumor malignancies.Spatial regulation of receptor tyrosine kinases in development and cancer.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Expression of EGFRvIII in thyroid carcinoma: immunohistochemical study by camel antibodies.c-Myc is required for transformation of FDC-P1 cells by EGFRvIII.Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha.Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines.Production and characterization of a new antibody specific for the mutant EGF receptor, EGFRvIII, in Camelus bactrianus.Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer.Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnosticsRegulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha.Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII.Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.
P2860
Q24650927-72CCC1E3-2926-4BC2-A03B-5DC8D785E027Q24815988-7CA62F64-BC45-44AA-8E04-FA016D6D016FQ27015045-043D1CCD-401F-4ED2-86F9-3B6FE74EED4AQ30480823-B96026CA-5E9F-48A1-AD30-4E7D34DDABD8Q33711627-98F34538-6902-4B59-A572-F76C26D69760Q33779199-62FC78A4-B422-4A08-9966-C40FD331CA33Q33793142-C4DD26D9-D48F-46A3-A452-381998FC2845Q34048283-493076E4-841A-4809-A236-31BFD4B3D72BQ34103963-BABEDC9D-8459-4245-B300-32B363EA40CAQ34120472-993DC5EC-CFDC-4A65-B327-85405C2ED4EEQ34346944-7B96889D-9E43-42BE-9EA9-AC1F20E670ACQ34470390-7EE28E37-BBD1-40F4-A8C0-2D55281DA0E4Q34488771-296C05EC-5C39-4922-9C19-883507EA76B5Q35114086-A25E5481-3FED-417A-9B83-9B56F6764CC3Q35216502-D52626AE-2B5B-4BC4-A0C8-232A843E121EQ36074410-8493FE96-BC17-4A45-8799-3139B7A316B4Q36214610-D084F401-AC0C-4A60-BFF0-26F22678B6AEQ36504349-7FA4D774-ED2D-4531-8A7A-F7523E4286CBQ37008823-D25C226A-D97E-4D4F-804B-AD5943FBB8B0Q37089778-300C6808-65B2-4D6F-8B25-996407BA784BQ37186248-22738889-2BD3-4350-9074-F222720485F0Q37259602-CA98EDCD-5060-49F9-B2CF-EF7B1E88F082Q37284242-D5E2DC22-5114-443A-9F43-2CC20CD060CEQ37362563-00413529-5356-4EF2-9B0F-CA2157CF38ECQ37533657-F4CC890B-304F-412F-92D1-ED40FEA94582Q37622619-17A828CE-A228-4072-B481-CA0AD16B86C3Q37690917-916B03AE-E8AE-4A68-97A9-AA33DEEFB951Q37990044-18AC10CD-C705-42B4-BC99-89397FD6D71EQ38012616-BE88F211-BE73-4582-A6B6-5AC047D194A4Q38255481-E54C1278-E7D8-4BD5-B0A3-922A50D2218FQ39866871-410CF284-AAC7-4B6F-BD96-B73DF4EC0CBAQ40133339-7F258FDF-D872-4C48-A0E6-0721320971C8Q40161836-8A312B32-93AC-485F-B3C7-8D84F0FD7DC6Q40378760-A12B0055-FC96-4512-B648-7DC50A6150E6Q40489069-6E3DC1C9-8AA7-4399-AF50-DDF05F290883Q41129659-AA380840-C57B-4EBE-A1A0-8E5421550ADBQ41885614-54CE5516-9D3E-44F9-AE21-B66118B0614DQ43005223-E524E5C5-37AB-4892-80A1-CAA262BE6199Q43200792-6262B57F-4F4C-4F74-87AB-06E0741ED2BDQ47135806-E5179ED9-844C-47BD-988A-61AD400BD297
P2860
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evidence of high incidence of ...... immunohistochemical analysis.
@ast
Evidence of high incidence of ...... immunohistochemical analysis.
@en
type
label
Evidence of high incidence of ...... immunohistochemical analysis.
@ast
Evidence of high incidence of ...... immunohistochemical analysis.
@en
prefLabel
Evidence of high incidence of ...... immunohistochemical analysis.
@ast
Evidence of high incidence of ...... immunohistochemical analysis.
@en
P2093
P2860
P356
P1476
Evidence of high incidence of ...... immunohistochemical analysis.
@en
P2093
Careen K Tang
Xiaoqi Gong
P2860
P304
P356
10.1002/IJC.10224
P577
2002-03-01T00:00:00Z